Position in CGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,251,249
+$7,872 QoQ
Shares Held
1,051,986
-0.1% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 82 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. CGEN ranks #205 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,251,249 | 1,051,986 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,243,377 | 1,053,229 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,544,841 | 1,009,701 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,557,812 | 1,059,737 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,339,124 | 1,314,116 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,025,392 | 1,387,256 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,255,126 | 820,345 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,368,080 | 755,847 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,266,608 | 753,935 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,963,384 | 761,002 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,527,902 | 771,669 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $728,510 | 783,347 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $887,347 | 778,376 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $554,536 | 792,197 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $533,089 | 740,406 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $706,243 | 1,070,069 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,073,354 | 1,120,733 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,811,611 | 1,183,731 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $5,515,071 | 1,282,575 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,691,087 | 1,623,298 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,820,924 | 1,789,967 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $14,026,971 | 1,632,942 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,369,846 | 1,186,610 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $21,539,081 | 1,325,482 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,523,649 | 1,033,532 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,314,247 | 869,731 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||